Gland
Live Price
Recent news and updates for GLAND will appear here soon.
"Robust technical setup for GLAND with strong AI conviction. The bullish trend in the healthcare space is accelerating while RSI at 58 suggests there is still significant room for upside before reaching overbought territory."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of pharmaceutical active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, blood related, cardiac, gastro-intestinal, gynaecological, hormones, neuro/Cns, ophthal/otological, and other areas, as well as pain/analgesics, respiratory and pulmonology, and vitamins, minerals, and nutrients. In addition, it provides contract development, dossier compilation, technology transfer services. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited operates as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
As of the latest market session, Gland (GLAND) is trading at ₹2,502.9, representing a move of -0.56% from the previous close.
Gland is listed and traded under the ticker symbol GLAND on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Gland's stock price moved by -0.56%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 83% bullish probability for GLAND stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Gland shares reached a high of ₹2,586 and hit a low of ₹1,573.6.
GLAND exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 2,66,828 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Gland has a market capitalization of ₹41324.15 Cr, designating its size class inside the Healthcare sector.
Gland has a current dividend yield of 80.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Gland's trailing Price-to-Earnings (P/E) ratio is 40.20. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Gland (GLAND) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Gland's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore GLAND's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for GLAND are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Gland operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.